CNBC March 26, 2024
Good afternoon! Inhalers will soon get a whole lot cheaper for some Americans.
Three of the world’s largest inhaler makers have agreed to cap the out-of-pocket price of their inhaler products and similar inhaled medicines at $35 a month for certain U.S. patients.
British drugmaker GlaxoSmithKline announced its cost cap last week following similar moves by AstraZeneca and the privately held Boehringer Ingelheim.
But there’s one holdout: Teva Pharmaceuticals, another major inhaler manufacturer, has not made a similar commitment.
The cost caps from the three other companies won’t go into effect immediately. They also didn’t come from out of nowhere.
In January, Sen. Bernie Sanders (I-Vt.) and other members of the Senate Committee on Health, Education,...
Today's Sponsors
Today's Sponsor